Physician profile
Alan L Zhang
NPI 1740445162
$246,671.09
in general payments reported to CMS, 2019-2025
6 companies · $48K in 2025
The $48K reported for 2025 was more than what 95% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $17K · 2021: $40K · 2022: $38K · 2023: $24K · 2024: $55K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $103K · Travel and Lodging: $16K · Food and Beverage: $4,643 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $102,825.00 |
| Travel and Lodging | $15,958.20 |
| Food and Beverage | $4,643.48 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $175,186.52 | 2019-2025 | Na, Insignia, Aequalis |
| Medical Device Business Services, INC. | $48,195.64 | 2021-2025 | Milagro, Monovisc, Rigidloop |
| Linvatec Corporation | $13,113.70 | 2023-2025 | Y-Knot, Biobrace 23mm, Linvatec Shoulder Arthroscopy |
| Depuy Synthes Products, INC. | $8,730.00 | 2020-2025 | Milagro, Monovisc, Rigidloop |
| Miach Orthopaedics, INC. | $1,108.71 | 2024-2025 | |
| Depuy Synthes Sales INC. | $336.52 | 2022-2025 | Dynacord, Healix Knotless Peek, Truespan Orthocord |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.